Monte Rosa Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
GLUE
CUSIP
61225M102
Type
Equity
Class
COM
Num filings
119
Total reported value, excl. options
$283 M
Manager Report Date Value ($000) Shares Option Type